Argenx Se (ARGX) Net Income Growth (1y) (2017 - 2026)
Argenx Se (ARGX) Net Income Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,681.27 Bn | 66,680.98 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 472.75 Bn | 467.96 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 122.14 Bn | 114.89 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 63.48% |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,228.66% |
| 10 | Revolution Medicines | 37.28 Bn | 37.28 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.48% |
| Mar 31, 2026 | 85.65% |
| Dec 31, 2025 | 535.59% |
| Sep 30, 2025 | 368.05% |
| Jun 30, 2025 | 1,575.97% |
| Mar 31, 2025 | 378.99% |
| Dec 31, 2024 | 237.06% |
| Sep 30, 2024 | 225.84% |
| Jun 30, 2024 | -123.87% |
| Mar 31, 2024 | -226.22% |
| Dec 31, 2023 | -239.48% |
| Sep 30, 2023 | -129.41% |
| Jun 30, 2023 | 109.76% |
| Mar 31, 2023 | -65.20% |
| Dec 31, 2022 | -82.59% |
| Sep 30, 2022 | 208.28% |
| Jun 30, 2022 | -702.14% |
| Mar 31, 2022 | 1,311.67% |
| Dec 31, 2021 | 229.43% |
| Sep 30, 2021 | -31.68% |